FDA and DEA Address 7-OH's Classification and Risks in Kratom
Tuesday, 19 August 2025, 09:19
FDA and DEA's Concerns Over 7-OH
The FDA has formally requested the DEA to impose a ban on the alkaloid 7-OH, a compound found in the kratom plant. This request cites a heightened risk of abuse and potential health risks associated with the compound.
Understanding 7-OH and Kratom
- 7-OH is an alkaloid derived from the kratom plant.
- This compound is often utilized for pain management and harm reduction.
- Experts debate its efficacy and risks as concerns over opioid alternatives rise.
Impacts of FDA's Request
If the DEA classifies 7-OH as a Schedule 1 drug, it would lead to significant legal implications under the Controlled Substances Act. This could restrict availability and further research on kratom and its benefits.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.